| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048470280 |
| P356 | DOI | 10.1186/S12879-015-1009-6 |
| P932 | PMC publication ID | 4527248 |
| P698 | PubMed publication ID | 26248711 |
| P5875 | ResearchGate publication ID | 280910708 |
| P50 | author | Valeriane Leroy | Q41071275 |
| Madeleine Amorissani-Folquet | Q42458440 | ||
| Patrick Ahuatchi Coffie | Q42459297 | ||
| Sylvie N'Gbeche | Q42459379 | ||
| Kouakou Kouadio | Q42459624 | ||
| Sophie Desmonde | Q56363438 | ||
| P2093 | author name string | Madeleine Amorissani-Folquet | |
| Patrick Ahuatchi Coffie | |||
| Karen Malateste | |||
| François Tanoh Eboua | |||
| Kouakou Kouadio | |||
| Clarisse Bosse-Amani | |||
| Sylvie N'Gbeche | |||
| Edmond Addi Aka | |||
| Aïda Mounkaila Harouna | |||
| Brou Kouacou | |||
| IeDEA paediatric West African Study Group | |||
| P2860 | cites work | Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | Q21034169 |
| Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review | Q21133667 | ||
| Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach | Q26859055 | ||
| Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis | Q27009235 | ||
| Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study | Q28139876 | ||
| Effect of investment in malaria control on child mortality in sub-Saharan Africa in 2002-2008 | Q28743029 | ||
| Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster | Q29614923 | ||
| Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009. | Q31020587 | ||
| Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors | Q33883605 | ||
| 12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008. | Q33947235 | ||
| Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance | Q33992235 | ||
| Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial | Q34369756 | ||
| The epidemiological impact of HIV antiretroviral therapy on malaria in children | Q35347170 | ||
| HIV infection and the incidence of malaria among HIV-exposed children from Tanzania | Q36153767 | ||
| Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children | Q36876420 | ||
| The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children | Q38462880 | ||
| Plasmodium falciparum infection in HIV-infected patients on highly active antiretroviral therapy (HAART) in Benin City, Nigeria. | Q38865138 | ||
| HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea | Q38868223 | ||
| Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children | Q38877477 | ||
| Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study | Q38879589 | ||
| The interaction between malaria and human immunodeficiency virus infection in severely anaemic Malawian children: a prospective longitudinal study. | Q39154381 | ||
| Antiretrovirals as antimalarial agents. | Q39469775 | ||
| Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi | Q40486195 | ||
| Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group | Q43836224 | ||
| Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. | Q47824850 | ||
| ART regimen protects children from malaria | Q56765812 | ||
| P921 | main subject | Ivory Coast | Q1008 |
| malaria | Q12156 | ||
| P304 | page(s) | 317 | |
| P577 | publication date | 2015-08-07 | |
| P1433 | published in | BMC Infectious Diseases | Q15759919 |
| P1476 | title | Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study | |
| P478 | volume | 15 |
| Q38843857 | Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial |
| Q56355771 | Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies |
| Q40097078 | Suboptimal Cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines |
| Q56909528 | Temporal Trends in Co-trimoxazole Use Among Children on Antiretroviral Therapy and the Impact of Co-trimoxazole on Mortality Rates in Children Without Severe Immunodeficiency |
Search more.